ME01876B - Upotreba antagonističkih anti-cd40 monoklonskih antitjela - Google Patents

Upotreba antagonističkih anti-cd40 monoklonskih antitjela

Info

Publication number
ME01876B
ME01876B MEP-2013-130A MEP13013A ME01876B ME 01876 B ME01876 B ME 01876B ME P13013 A MEP13013 A ME P13013A ME 01876 B ME01876 B ME 01876B
Authority
ME
Montenegro
Prior art keywords
monoclonal antibodies
antagonistic anti
antagonistic
monoclonal
antibodies
Prior art date
Application number
MEP-2013-130A
Other languages
English (en)
Inventor
Li Long
Mohammed Luqman
Asha Yabannavar
Isabel Zaror
Sang Hoon Lee
Deborah Hurst
Bao-Lu Chen
Xiaofeng Lu
Original Assignee
Novartis Vaccines & Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostics Inc filed Critical Novartis Vaccines & Diagnostics Inc
Priority claimed from EP09075395.5A external-priority patent/EP2149585B1/en
Publication of ME01876B publication Critical patent/ME01876B/me

Links

MEP-2013-130A 2003-11-04 2004-11-04 Upotreba antagonističkih anti-cd40 monoklonskih antitjela ME01876B (me)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51733703A 2003-11-04 2003-11-04
US52557903A 2003-11-26 2003-11-26
US56571004A 2004-04-27 2004-04-27
EP09075395.5A EP2149585B1 (en) 2003-11-04 2004-11-04 Use of antagonistic anti-CD40 monoclonal antibodies

Publications (1)

Publication Number Publication Date
ME01876B true ME01876B (me) 2014-12-20

Family

ID=58463994

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-130A ME01876B (me) 2003-11-04 2004-11-04 Upotreba antagonističkih anti-cd40 monoklonskih antitjela

Country Status (2)

Country Link
CY (1) CY1114654T1 (me)
ME (1) ME01876B (me)

Also Published As

Publication number Publication date
CY1114654T1 (el) 2016-12-14

Similar Documents

Publication Publication Date Title
PL1707627T3 (pl) Mutant antagonistycznego przeciwciała anty-CD40
IL149701A0 (en) Use of anti-ctla-4 antibodies
IL175935A0 (en) Solid forms of anti-egfr antibodies
SI1587542T1 (sl) Uporaba anti-cd100 protiteles
IL177602A0 (en) Uses of anti-ctla-4 antibodies
GB0305702D0 (en) Bispecific antibodies
IL179672A (en) Monoclonal antibodies against 3 cd human
IL191117A0 (en) Uses of anti-cd40 antibodies
AU2002251562A1 (en) Anti-CD40 monoclonal antibody
IL168304A (en) Human monoclonal antibodies against cd25
IL200604A0 (en) Human monoclonal antibodies against cd30
CY2012019I2 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
EP1658095A4 (en) ANTI-CD3 ANTIBODY DESIMMUNISE
IL173317A0 (en) Anti-vegf antibodies
IL205511A0 (en) Methods and compositions for the production of monoclonal antibodies
HUP0500816A3 (en) Antagonistic anti-htnfsf13b human antibodies
IL175608A0 (en) Antibodies
IL173557A0 (en) Variable antibodies
AU2003220079A8 (en) Uses of monoclonal antibody 8h9
AU2003277832A8 (en) Humanized tissue factor antibodies
IL172533A0 (en) Humanized anti-ccr2 antibodies and methods of use
ME01876B (me) Upotreba antagonističkih anti-cd40 monoklonskih antitjela
SI2149585T1 (sl) Uporaba antagonističnih ANTI-CD40 monoklonskih protiteles
AU2003229799A1 (en) Novel humanized anti-vap-1 monoclonal antibody
EP1813668A4 (en) HYBRIDOM capable of producing a monoclonal anti-DECTIN-1 antibody